Experimental Ascites

Orloff, Marshall J.; Baddeley, Richard M.; Ross, Thomas H.; Nutting, R O; Thomas, Horn; Halasz, Nicholas A.; Sloop, Richard D.

doi:10.1097/00000658-196502000-00015

Cited by 23 publications

(2 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additionally, a single patent hepatic vein was sufficient to prevent the development of ascites in dogs with experimentally induced obstruction. 24 Two dogs each received 2 stents (1 stent in the left hepatic vein and 1 stent in the CaVC); however, the third dog only received a stent in the left hepatic vein because of the cardiac arrhythmias and changes in blood pressure during manipulations to structures around the tumor.…”

Section: Discussionmentioning

confidence: 99%

“…Complications in humans include fracture, migration, reocclusion, and misplacement of stents. 24 Additional complications include non-life-threatening hemorrhage from the vascular access site and procedure-related arrhythmias. 23 Two of the dogs reported here had cardiac arrhythmias, only 1 of which required treatment, that were likely attributable to an underly-…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Use of endovascular stents in three dogs with Budd-Chiari syndrome

Schlicksup

Weisse²,

Berent³

et al. 2009

javma

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Use of endovascular stents in three dogs with Budd-Chiari syndrome

Schlicksup

Weisse²,

Berent³

et al. 2009

javma

View full text Add to dashboard Cite

show abstract

Experimental Ascites

Orloff¹,

Wright²,

DeBENEDETTI³

et al. 1966

Arch Surg

View full text Add to dashboard Cite

A Comparison of Acute Reversible Pre- and Postsinusoidal Portal Hypertension on Salt and Water Retention in the Dog

et al. 2007

View full text Add to dashboard Cite

To define the relationship between portal hypertension and renal excretion of salt and water, two acute animal models of portal hypertension were investigated. In both models, it was necessary for systemic and renal hemodynamics to remain unchanged during the creation of portal hypertension so as to eliminate the effects of change in these parameters on renal excretion.In eight dogs, portal hypertension was induced by controlled tightening of a ligature around the superior hepatic vein and changes in hemodynamics were prevented by controlled i.v. titration with canine plasma. Rises in portal pressure 9.3 k 2.6 to 15.6 f 2.3 cm HZO were associated with significant decreases in urine volume 1.57 k 0.53 to 0.66 k 0.21 ml per min (p < 0.05) and urinary sodium excretion 1340 & 82 to 145 k 76 mEq per min (p < 0.05)]. In contrast, similar experiments in five dogs in which the portal vein was partially ligated with increases in portal pressure from 8.3 f 0.6 to 18.6 & 0.5 cm HzO resulted in no change in urinary volume or sodium excretion.Acute reversible portal hypertension induced by hepatic vein constriction is associated with acute reversible retention of water and salt in the absence of changes in renal blood flow and creatinine clearance which only occur when the liver is involved and not with portal vein constriction.Many patients with advanced cirrhosis develop renal sodium retention and ascites. In the past, this sodium retention has been thought to be the result of fluid loss into the ascitic "third space" secondary to increased hydrostatic pressure in the hepatic sinusoids and splanchnic capillaries with a decrease in effective circulatory volume and appropriate alteration in renin and aldosterone secretion. Although plasma volume measurements in cirrhotics are actually normal or slightly elevated, it has been postulated that the ('central'' or nonsplanchnic component is decreased and the splanchnic component increased. Lieberman, in 1969, presented data from studies in human cirrhosis which suggested that renal sodium retention actually preceded the development of ascites, and was in fact, a contributing factor in the development of ascites (1). He postulated the existence of some hepatic factors which altered renal sodium handling independent of volume changes and the reninaldosterone regulatory mechanisms.

show abstract

Experimental Ascites

Cited by 23 publications

References 2 publications

Use of endovascular stents in three dogs with Budd-Chiari syndrome

Use of endovascular stents in three dogs with Budd-Chiari syndrome

Experimental Ascites

A Comparison of Acute Reversible Pre- and Postsinusoidal Portal Hypertension on Salt and Water Retention in the Dog

Contact Info

Product

Resources

About